文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号（下記リストの赤色の数字）を入力の上、ご連絡ください。
244
Combination of urinary biomarkers can predict cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis.
Ann Intensive Care. 2025.
doi: 10.1186/s13613-025-01459-7.PubMed
doi: 10.1186/s13613-025-01459-7.PubMed
243
Urinary biomarkers in prediction of subclinical acute kidney injury in pediatric oncology patients treated with nephrotoxic agents.
BMC Nephrol. 2025.
doi: 10.1186/s12882-025-04085-4.PubMed
doi: 10.1186/s12882-025-04085-4.PubMed
241
Liver fatty acid-binding protein point-of-care testing detects heat-induced organ damage: a pilot study in Japanese male self-defense force personnel.
Sci Rep. 2025.
doi: 10.1038/s41598-025-91685-7.PubMed
doi: 10.1038/s41598-025-91685-7.PubMed
240
The feasibility of point-of-care testing for initial urinary liver fatty acid-binding protein to estimate severity in severe heatstroke.
239
Prognostic values of proteinuria in patients with acute heart failure.
238
The Urinary Liver-Type Fatty Acid Binding Protein (L-FABP) in Early Detection and Outcome Prediction of Sepsis-Associated Acute Kidney Injury.
236
Clustering based on renal and inflammatory admission parameters in critically ill patients admitted to the ICU.
233
ISCCM Guidelines on Acute Kidney Injury and Renal Replacement Therapy.
230
Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study.
Ann Intensive Care. 2024
doi: 10.1186/s13613-024-01328-9. PubMed
doi: 10.1186/s13613-024-01328-9. PubMed
229
Urinary liver-type fatty acid-binding protein level as a prognostic indicator of acute kidney injury secondary to severe falciparum malaria.
CEN Case Rep. 2024
doi: 10.1007/s13730-024-00886-y. PubMed
doi: 10.1007/s13730-024-00886-y. PubMed
228
Urinary L-FABP as an Early Biomarker for Pediatric Acute Kidney Injury Following Cardiac Surgery with Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2024
doi: 10.3390/ijms25094912. PubMed
doi: 10.3390/ijms25094912. PubMed
227
Urinary liver-type fatty acid-binding protein levels may be associated with the occurrence of acute kidney injury induced by trauma.
Front Med (Lausanne). 2024
doi: 10.3389/fmed.2024.1346183.PubMed
doi: 10.3389/fmed.2024.1346183.PubMed
225
Urine oxygenation predicts COVID 19 risk.
Clin Exp Nephrol. 2024
doi: 10.1007/s10157-023-02456-5.PubMed
doi: 10.1007/s10157-023-02456-5.PubMed
223
Unravelling the role of urinary liver-type fatty acid binding protein in histone-induced AKI.
Nephrology (Carlton). 2024
doi: 10.1111/nep.14271.PubMed
doi: 10.1111/nep.14271.PubMed
222
How to Construct an Optimal Risk Model for Contrast-induced Nephropathy.
Intern Med. 2024
doi: 10.2169/internalmedicine.3209-23.PubMed
doi: 10.2169/internalmedicine.3209-23.PubMed
221
The Experience of Using Urinary Liver-Type Fatty Acid-Binding Protein for Follow-Up of Toluene Poisoning: A Case Report.
Cureus. 2023
doi: 10.7759/cureus.50438.PubMed
doi: 10.7759/cureus.50438.PubMed
220
Evaluation of amniotic fluid neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein levels during pregnancy.
Eur J Obstet Gynecol Reprod Biol X. 2023
doi: 10.1016/j.eurox.2023.100269.PubMed
doi: 10.1016/j.eurox.2023.100269.PubMed
219
Predictive Performance of Neutrophil Gelatinase Associated Lipocalin, Liver Type Fatty Acid Binding Protein, and Cystatin C for Acute Kidney Injury and Mortality in Severely Ill Patients.
Ann Lab Med. 2024
doi: 10.3343/alm.2023.0083.PubMed
doi: 10.3343/alm.2023.0083.PubMed
217
Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury.
Nephrology (Carlton). 2023
doi: 10.1111/nep.14254.PubMed
doi: 10.1111/nep.14254.PubMed
216
Subclinical and clinical acute kidney injury share similar urinary peptide signatures and prognosis.
Intensive Care Med. 2023
doi: 10.1007/s00134-023-07198-2.PubMed
doi: 10.1007/s00134-023-07198-2.PubMed
215
Biomarker array for prediction of acute kidney injury after percutaneous coronary intervention for patients who had acute ST segment elevation myocardial infarction.
Heart Vessels. 2023
doi: 10.1007/s00380-023-02330-0.PubMed
doi: 10.1007/s00380-023-02330-0.PubMed
213
Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation.
Sci Rep. 2023
doi: 10.1038/s41598-023-46015-0.PubMed
doi: 10.1038/s41598-023-46015-0.PubMed
212
Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation.
Transplant Cell Ther. 2023
doi: 10.1016/j.jtct.2023.10.003.PubMed
doi: 10.1016/j.jtct.2023.10.003.PubMed
209
Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone.
Nephrology (Carlton). 2023
DOI: 10.1111/nep.14162PubMed
DOI: 10.1111/nep.14162PubMed
208
Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases.
Care Explor. 2023
doi: 10.1097/CCE.0000000000000873.PubMed
doi: 10.1097/CCE.0000000000000873.PubMed
204
Evaluation of Urine L-FABP Point of Care Kit in the Philippines as Predictive Marker of Clinical Severity of COVID-19 (EPOCH COVID study).
Philipp J Intern Med. 2022PJIM
203
Clinical utility of tubular markers in kidney disease: a narrative review.
J Lab Precis Med. 2022JLPM
202
Urinary liver-type fatty acid-binding protein: A hemodynamic index during extracorporeal membrane oxygenation.
Clin Case Rep. 2022
doi: 10.1002/ccr3.6531PubMed
doi: 10.1002/ccr3.6531PubMed
198
Utility of urinary liver-type fatty acid-binding protein as a prognostic marker in adult congenital heart patients hospitalized for acute heart failure.
Heart Vessels. 2022
doi: 10.1007/s00380-022-02174-0PubMed
doi: 10.1007/s00380-022-02174-0PubMed
195
Early biomarkers for kidney injury in heat-related illness patients: a prospective observational study at Japanese Self-Defense Force Fuji Hospital.
Nephrol Dial Transplant. 2022
doi: 10.1093/ndt/gfac166.PubMed
doi: 10.1093/ndt/gfac166.PubMed
194
Xanthine Oxidoreductase Activity in Marathon Runners: Potential Implications for Marathon-Induced Acute Kidney Injury.
J Appl Physiol. 2022
doi: 10.1152/japplphysiol.00669.2021.PubMed
doi: 10.1152/japplphysiol.00669.2021.PubMed
193
Urinary Biomarkers Can Predict Weaning From Acute Dialysis Therapy in Critically Ill Patients.
Arch Pathol Lab Med. 2022
doi: 10.5858/arpa.2021-0411-OA.PubMed
doi: 10.5858/arpa.2021-0411-OA.PubMed
192
Urine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries.
Int J Infect Dis. 2022
doi: 10.1016/j.ijid.2022.02.024.PubMed
doi: 10.1016/j.ijid.2022.02.024.PubMed
191
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
J Clin Apher. 2021
doi: 10.1002/jca.21861.PubMed
doi: 10.1002/jca.21861.PubMed
190
Biomarkers for the early prediction of contrast-induced nephropathy after percutaneous coronary intervention in adults: A systematic review and meta-analysis.
Angiology. 2022PubMed
188
Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury.
BMC Nephrol. 2022
doi: 10.1186/s12882-022-02760-4.PubMed
doi: 10.1186/s12882-022-02760-4.PubMed
187
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes.
J Thromb Thrombolysis. 2022
doi: 10.1007/s11239-022-02631-7.PubMed
doi: 10.1007/s11239-022-02631-7.PubMed
186
The Role of Urine Liver Fatty Acid Binding Protein in Early Detection of Acute Kidney Injury in Septic Patient.
Egypt J Crit Care Med. 2022
doi: 10.1097/EJ9.0000000000000019PubMed
doi: 10.1097/EJ9.0000000000000019PubMed
185
Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failure.
ESC Heart Fail. 2022
doi: 10.1002/ehf2.13730.PubMed
doi: 10.1002/ehf2.13730.PubMed
184
Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures.
Cardiorenal Med. 2022
doi: 10.1159/000520820.PubMed
doi: 10.1159/000520820.PubMed
183
Hemodynamics and Metabolic Parameters in Normothermic Kidney Preservation Are Linked With Donor Factors, Perfusate Cells, and Cytokines.
Front Med (Lausanne). 2022
doi: 10.3389/fmed.2021.801098. eCollection 2021.PubMed
doi: 10.3389/fmed.2021.801098. eCollection 2021.PubMed
180
Quantitative and qualitative analyses of urinary L-FABP for predicting acute kidney injury after emergency laparotomy.
J Anesth. 2021
doi: 10.1007/s00540-021-03003-w.PubMed
doi: 10.1007/s00540-021-03003-w.PubMed
177
Accuracy of Liver-Type Fatty Acid-Binding Protein in Predicting Acute Kidney Injury: A Meta-Analysis.
J Appl Lab Med. 2021
doi: 10.1093/jalm/jfab092.PubMed
doi: 10.1093/jalm/jfab092.PubMed
176
Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs.
J Vet Med Sci. 2021PubMed
175
Clinical Utility of Urinary Biomarkers for Prediction of Acute Kidney Injury and Chronic Renal Dysfunction After Open Abdominal Aortic Aneurysm Repair.
Int J Nephrol Renovasc Dis. 2021
doi: 10.2147/IJNRD.S322916.PubMed
doi: 10.2147/IJNRD.S322916.PubMed
173
Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio isrelated to worsening renal function in patients undergoing elective percutaneous coronary intervention.
Clin Exp Nephrol. 2021
doi: 10.1007/s10157-021-02113-9.PubMed
doi: 10.1007/s10157-021-02113-9.PubMed
172
First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.
Open Forum Infect Dis. 2021
doi: 10.1093/ofid/ofab274.PubMed
doi: 10.1093/ofid/ofab274.PubMed
171
COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine.
Clin Exp Nephrol. 2021
doi: 10.1007/s10157-021-02101-z.PubMed
doi: 10.1007/s10157-021-02101-z.PubMed
170
Assessment of Cardiopulmonary Bypass Duration Improves Novel Biomarker Detection for Predicting Postoperative Acute Kidney Injury after Cardiovascular Surgery.
J Clin Med. 2021
doi: 10.3390/jcm10132741.PubMed
doi: 10.3390/jcm10132741.PubMed
169
Urinary liver-type fatty acid-binding protein variation as a predictive value of short-term mortality in intensive care unit patients.
Ren Fail. 2021
doi: 10.1080/0886022X.2021.1943439.PubMed
doi: 10.1080/0886022X.2021.1943439.PubMed
159
Urinary liver-type fatty acid-binding protein is independently associated with graft failure in outpatient kidney transplant recipients.
Am J Transplant. 2020
doi: 10.1111/ajt.16312.PubMed
doi: 10.1111/ajt.16312.PubMed
156
Urinary biomarkers of kidney tubule injury, risk of acute kidney injury, and mortality in patients with acute ischaemic stroke treated at a stroke care unit.
Eur J Neurol. 2020
doi: 10.1111/ene.14448.PubMed
doi: 10.1111/ene.14448.PubMed
155
Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers.
Crit Care Explor. 2020
doi: 10.1097/CCE.0000000000000170.PubMed
doi: 10.1097/CCE.0000000000000170.PubMed
150
Urinary Liver-Type Fatty-Acid-Binding Protein Predicts Long-Term Adverse Outcomes in Medical Cardiac Intensive Care Units.
J Clin Med. 2020PubMed
147
Novel Urinary Biomarkers for Acute Kidney Injury and Prediction of Clinical Outcomes After Pediatric Cardiac Surgery.
Pediatr Cardiol. 2019PubMed
143
Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advanced hyperparathyroidism.
Clin Kidney J. 2019PubMed
142
Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study.
J Vet Med Sci. 2019PubMed
141
Clinical significance of urinary L-FABP in the emergency department.
Int J Emerg Med. 2019PubMed
136
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice.
Naunyn Schmiedebergs Arch Pharmacol. 2018PubMed
135
Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.
Crit Care. 2018PubMed
133
Increased urinary liver-type fatty acid-binding protein level predicts worsening renal function in patients with acute heart failure.
J Card Fail. 2018PubMed
132
Urinary Liver Type Fatty Acid Binding Protein Is Negatively Associated With Estimated Glomerular Filtration Rate in Renal Transplant Recipients With Graft Loss.
Transplant Proc. 2018PubMed
128
Urinary Liver-Type Fatty Acid-Binding Protein Level as a Predictive Biomarker of Acute Kidney Injury in Patients with Acute Decompensated Heart Failure.
Cardiorenal Med. 2017PubMed
127
Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography.
QJM. 2018PubMed
122
Values of combination of urinary L-FABP and NGAL in early diagnosis of acute kidney injury after cardiac surgery in children.
Scand J Clin Lab Invest. 2017PubMed
116
Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia-reperfusion.
Nephrology. 2017PubMed
115
The protective effect of human atrial natriuretic peptide on renal damage during cardiac surgery.
J Anesth. 2016PubMed
112
Urinary l-type fatty acid-binding protein is a predictor of early renal function after partial nephrectomy.
Ren Fail. 1-6, 2016PubMed
110
Impact of clinical context on acute kidney injury biomarker performances: differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein.
Sci Rep. 2016PubMed
109
First Post-Operative Urinary Kidney Injury Biomarkers and Association with the Duration of AKI in the TRIBE-AKI Cohort.
PLoS One. 11(8):e0161098PubMed
R30
Acute Kidney Injury after Cardiac Surgery: Risk Factors and Novel Biomarkers.
Braz J Cardiovasc Surg. 2019PubMed
R27
The ischemic/nephrotoxic Acute Kidney Injury and the use of renal biomarkers in clinical practice.
Eur J Intern Med. 2016PubMed
R26
The potential use of biomarkers in predicting contrast-induced acute kidney injury.
Int J Nephrol Renovasc Dis. 2016PubMed
R25
Biomarkers in acute kidney injury ? pathophysiological basis and clinical performance.
Acta Physiol. 2016PubMed
R24
Bench to Bedside: The next steps for biomarkers in acute kidney injury.
Am J Physiol Renal Physiol. 311(4):F717-F721, 2016PubMed
108
Comparison of three early biomarkers for acute kidney injury after cardiac surgery under cardiopulmonary bypass.
J Intensive Care. 4(41), 2016.PubMed
105
Novel urinary tubular injury markers reveal an evidence of underlying kidney injury in children with reduced left ventricular systolic function: a pilot study.
Pediatr Nephrol. 2016.PubMed
103
Urinary L-FABP as a mortality predictor among < 5 septic children in Bangladesh.
Pediatr Int. 185-191, 2016.PubMed
98
Follow-Up Renal Assessment of Injury Long-Term After Acute Kidney Injury (FRAIL-AKI).
Clin J Am Soc Nephrol. 11(1):21-29, 2015.PubMed
97
Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair.
J Anesth. 30(1): 89-99. 2015.PubMed
93
Urinary, Plasma, and Serum Biomarkers’ Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis.
Am J Kidney Dis. 66(6):993-1005, 2015.PubMed
92
Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events.
Int J Nephrol Renovasc Dis. 8: 91-99, 2015.PubMed
90
Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.
Heart Vessels. 30(3): 296-303, 2015.PubMed
86
Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in Critically Ill Children (AWARE): study protocol for a prospective observational study.
BMC Nephrol. 16(24), 2015.PubMed
83
Pediatric reference ranges for acute kidney injury biomarkers.
Pediatr Nephrol. 30(4): 677-685, 2015.PubMed
79
Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.
Am J Physiol Renal Physiol. 308(2): F114-121, 2014.PubMed
78
Early prediction of acute kidney injury biomarkers after endovascular stent graft repair of aortic aneurysm: a prospective observational study.
J Intensive Care. 2(45), 2014.PubMed
76
Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation.
Biol Blood Marrow Transplant. 20(12): 2010-2014, 2014.PubMed
75
A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care.
J Infect Chemother. 21(3): 165-169, 2014.PubMed
73
Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.
Kidney Int. 87(3): 640-648, 2014.PubMed
69
Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit.
Nephrol Dial Transplant. 29(1): 73-80, 2014.PubMed
68
Urinary biomarkers and progression of AKI in patients with cirrhosis.
Clin J Am Soc Nephrol. 9(11): 1857-1867, 2014.PubMed
67
Biomarkers of acute kidney injury in pediatric cardiac surgery.
Clin Biochem. 46(13-14): 1244-1251, 2013.PubMed
66
Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis.
Am J Kidney Dis. 61(3): 430-439, 2013.PubMed
65
Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.
Clin J Am Soc Nephrol. 8(7): 1079-1088, 2013.PubMed
64
Remote Ischemic Pre-Conditioning Alleviates ContrastInduced Acute Kidney Injury in Patients With Moderate Chronic Kidney Disease.
Circulation Journal. 77(12): 3037-3044, 2013.PubMed
61
The role of urinary liver-type fatty acid-binding protein in critically ill patients.
J Korean Med Sci. 28(1): 100-105, 2013.PubMed
59
Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome.
J Cardiol. 60(3): 168-173, 2012.PubMed
57
Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.
Eur J Clin Invest. 42(5): 557-563, 2012.PubMed
55
Usefulness of Urinary Biomarkers in Early Detection of Acute Kidney Injury After Cardiac Surgery in Adults.
Circulation Journal. 76(1): 213-220, 2012.PubMed
54
Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery.
Ann Thorac Surg. 93(2): 577-583, 2012.PubMed
53
Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury.
Hypertension. 60(4): 973-980, 2012.PubMed
52
Mild elevation of urinary biomarkers in prerenal acute kidney injury.
Kidney Int. 82(10): 1114-1120, 2012.PubMed
49
Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.
J Am Coll Cardiol. 58(22): 2301-2309, 2011.PubMed
47
Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
Am J Pathol. 178(3): 1021-1032, 2011.PubMed
46
Clinical significance of tubular and podocyte biomarkers in acute kidney injury.
Clin Exp Nephrol. 15(2): 220-225, 2011.PubMed
43
Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.
Crit Care Med. 39(11): 2464-2469, 2011.PubMed
42
Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury.
Crit Care Med. 38(10): 2037-2042, 2010PubMed
36
Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.
Am J Pathol. 174(6): 2096-2106, 2009.PubMed
35
Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury.
Am J Pathol. 174(4): 1203-1211, 2009.PubMed
32
Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury.
Am J Pathol. 174(4): 1154-1159, 2009.PubMed
31
Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
Shock. 31(5): 454-459, 2009.PubMed
28
Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury.
Nephron Exp Nephrol. 108(1): e19-26, 2008.PubMed
27
Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery.
Kidney Int. 73(4): 465-472, 2008.PubMed
26
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.
Kidney Int. 73(12): 1374-1384, 2008.PubMed
23
L-Type Fatty Acid Binding Protein Transgenic Mouse as a Novel Tool to Explore Cytotoxicity to Renal Proximal Tubules.
Drug Metab. Pharmacokinet. 23(4): 271-278, 2008.PubMed
22
Renal L-type fatty acid-binding protein in acute ischemic injury.
J Am Soc Nephrol. 18(11): 2894-2902, 2007.PubMed
18
A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure.
Kidney Int. 72(3): 348-358, 2007.PubMed
17
Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
Am J Kidney Dis. 47(3): 439-444, 2006.PubMed
9
Quantification of L-type fatty acid binding protein in the urine of preterm neonates.
Early Hum Dev. 81(7): 643-646, 2005.PubMed
